1. (a) Dentists administering minimal sedation shall:

   1. (1) Follow the clinical guidelines set forth in Part IV A. of the American Dental Association “Guidelines for the Use of Sedation and General Anesthesia by Dentists” revised 2016 or in the American Academy of Pediatrics “Guidelines for Monitoring and Management of Pediatric Patients Before, During and After Sedation for Diagnostic and Therapeutic Procedures” revised 2019, as specified in Appendix II including having a properly staffed and equipped facility and reversal agents available for any enteral drugs administered, specific to the age demographic of the patient being treated; and
   2. (2) Hold a current pediatric minimal sedation permit when treating patients under 13 years of age.

2. (b) The following routes of administration shall apply to the use of minimal sedation:

   1. (1) Inhalation using nitrous oxide;
   2. (2) A single dose, as defined in Den 304.01(r), of one enteral drug establishing a margin of safety wide enough to render unintended loss of consciousness unlikely, using manufacturer guidelines as found in the FDA “Online Label Repository” found at labels.fda.gov; or
   3. (3) If the patient is 13 years of age or older a combination inhalation-enteral, as above in (1) and (2).
3. (c) A minimum of one staff member trained in the monitoring and resuscitation of pediatric patient, in addition to the dentist administering minimal sedation, shall be present for administration of minimal sedation to patients under 13 years of age, pursuant to RSA 317-A:12, XII-c(f).

Source. #12428, eff 12-6-17; amd by #12549, eff 6-15-18; ss by #14246, eff 8-3-25, EXPIRES: 8-3-35 (formerly Den 304.06)